IMMX

Immix Biopharma Inc

NASDAQ: IMMX · HEALTHCARE · BIOTECHNOLOGY

$10.10

+0.90% today

Updated 2026-06-03

Market cap

$620.78M

P/E ratio

—

P/S ratio

—

EPS (TTM)

$-0.92

Dividend yield

—

52W range

$2 – $12

Volume

1.3M

Market cap

$620.78M

P/E ratio

—

P/S ratio

—

EPS (TTM)

$-0.92

Dividend yield

—

52W range

$2 – $12

Volume

1.3M

WallStSmart proprietary scores

out of 100

Grade: F

Strong Sell

Investment rating

4.3

Growth

8.5

Quality

3.0

Profitability

5.0

Valuation

C+

3/9

Piotroski F-Score

Weak

3.8

Altman Z-Score

Safe zone

—

Industry rank

—

View all highly rated stocks (75+) →199 stocks currently score above 75

Price targets

Analyst target

$19.75

+95.54%

12-Month target

—

Intrinsic (DCF)

—

Margin of safety

—

2 Strong Buy2 Buy0 Hold0 Sell0 Strong Sell

Price chart

Stock snapshot

Strengths

+ Altman Z 3.82 — safe zone

+ Debt/equity 0.01x — low leverage

Risks

- Piotroski 3/9 — weak financial health

- Thin margins at 0.00%

- Negative free cash flow $-9.86M

Key financials

Revenue Net Income Free Cash Flow

Metric	2022	2023	2024	2025	TTM
Revenue	$-89.52M	$0.00	$0.00	$0.00	$0.00
Net income	$-8.23M	$-15.43M	$-21.61M	$-29.44M	$-10.09M
EPS	—	—	—	—	$-0.92
Free cash flow	$-7.41M	$-11.42M	$-15.77M	$-24.66M	$-9.86M
Profit margin	9.19%	—	—	—	—

Recent insider activity

Date	Insider	Type	Shares	Price
2026-05-22	RACHMAN, ILYA M	Buy	500,000	—
2026-05-22	NG, CAREY	Buy	12,500	—
2026-05-22	NG, CAREY	Buy	6,250	—

Peer comparison

Company	Mkt Cap	Score	Growth	Profit	Value	Quality	MoS	Rating
IMMX	$620.78M	20	4.3	3.0	5.0	8.5	—	Avoid
LLY	$1.01T	76	10.0	10.0	4.3	6.0	—	Strong Buy
JNJ	$567.28B	57	4.7	9.0	3.3	6.0	-67.79%	Buy
ABBV	$391.50B	63	4.0	8.0	4.0	5.0	-48.06%	Buy
UNH	$373.28B	54	5.3	5.5	4.0	5.5	-24.80%	Buy
NVS	$289.19B	49	3.3	9.0	3.3	4.5	-62.62%	Hold

Smart narrative

Immix Biopharma Inc trades at $10.10. Our Smart Value Score of 20/100 indicates the stock is weak. The company scores 3/9 on the Piotroski F-Score. With an Altman Z-Score of 3.82, it sits in the safe zone.

Frequently asked questions

What is Immix Biopharma Inc's stock price?

Immix Biopharma Inc (IMMX) trades at $10.10.

Is Immix Biopharma Inc overvalued?

Immix Biopharma Inc carries a Smart Value Score of 20/100 (Grade F), which we rate Strong Sell. That score blends growth, quality, and valuation into one read.

What is the price target of Immix Biopharma Inc (IMMX)?

The 12-month analyst consensus target is $19.75, about 95.5% above the current $10.10. A consensus target is the average of Wall Street's 12-month forecasts, so it works as a sentiment gauge rather than a guarantee, and it resets with every earnings cycle.

Altman Z-Score?

Immix Biopharma Inc's Altman Z-Score is 3.82, which places it in the safe zone. The Altman Z-Score gauges bankruptcy risk from profitability, leverage, and asset efficiency, and a higher reading points to lower financial distress risk.

Company info

SectorHEALTHCARE

IndustryBIOTECHNOLOGY

CountryUSA

ExchangeNASDAQ

CurrencyUSD

Quick metrics

P/S ratio—

ROE-41.47%

Beta0.11

50D MA$9.23

200D MA$6.30

Shares out0.07B

Float0.04B

Short ratio—

Avg volume1.3M

Performance

1 week+0.00%

1 month-3.87%

3 months-4.20%

YTD+61.38%

1 year—

3 years—

5 years—

Compare

IMMX vs LLY →IMMX vs JNJ →IMMX vs ABBV →Stock screener →